Methods and systems for closed-loop control of drug administration

Patent metadata

Field	Value
Publication number	US-11266780-B2
Application number	US-201615979661-A
Country	US
Kind code	B2
Filing date	Nov 23, 2016
Priority date	Nov 23, 2015
Publication date	Mar 8, 2022
Grant date	Mar 8, 2022

Abstract

A control system for administration of a drug comprises a drug administration actuator for administering the drug to a patient at a controllable dosage; a monitor for measuring an effect of the drug on the patient; and a controller configured to determine a control signal to the drug administration actuator; wherein the controller is configured to implement a closed loop model-predictive control scheme comprising, for each of a series of time steps, minimizing a cost function subject to one or more constraints to determine the control signal, the cost function based at least in part on a reference level and the monitor measurement; wherein the control signal is used as an input to an auxiliary model to estimate at least one concentration level of the drug in the patient; and wherein the constraints comprise at least one constraint on the estimate of the concentration level of the drug.

First claim

What is claimed is:

1. A control system for closed loop control of administration of at least one drug to a patient, the control system comprising:
a drug administration actuator connectable to a source of the at least one drug and to a patient for administration of the at least one drug to the patient at a controllable drug dosage rate;
one or more monitors for sensing one or more monitored physiological characteristics of the patient and determining therefrom a monitor measurement indicative of an effect of the at least one drug on the patient; and
a processor configured, for each of a series of time steps, to determine a control signal and supply the control signal to the drug administration actuator to thereby cause the drug administration actuator to administer the at least one drug to the patient at a drug dosage rate which causes the monitor measurement to track a reference level;
wherein the processor is configured to implement a closed loop model-predictive control scheme which comprises, for each of the series of time steps, minimizing a cost function (performance index) subject to one or more constraints to thereby determine the control signal, the cost function based at least in part on the reference level and the monitor measurement;
wherein the processor is configured to use the control signal as an input to an auxiliary model and to use the auxiliary model and the control signal to estimate at least one concentration level of the at least one drug in the patient;
wherein the one or more constraints comprise at least one constraint on the estimate of the at least one concentration level of the at least one drug;
wherein the processor is configured to implement a robust model-predictive control scheme;
wherein the robust model-predictive control scheme causes the monitor measurement to track the reference level despite inter-patient variability within a population with respect to the effect of the at least one drug; and
wherein processor is configured to implement the robust model-predictive control scheme by using a nominal model that has been tuned with respect to quantified inter-patient uncertainty.

2. The control system of claim 1 wherein the nominal model is based on a combination of models from the population, with each model representing an effect of the drug on a corresponding member of the population.

3. The control system of claim 2 wherein the combination of models comprises an average of the models over the population.

4. The control system of claim 1 wherein the drug administration actuator comprises a controllable drug injection device.

5. The control system of claim 4 wherein the processor is configured, for each of the series of time steps, to determine the control signal and supply the control signal to the controllable injection device to thereby cause the controllable injection device to administer the at least one drug to the patient at a drug infusion rate which causes the monitor measurement to track the reference level.

6. A control system for closed loop control of administration of at least one drug to a patient, the control system comprising:
a drug administration actuator connectable to a source of the at least one drug and to a patient for administration of the at least one drug to the patient at a controllable drug dosage rate;
one or more monitors for sensing one or more monitored physiological characteristics of the patient and determining therefrom a monitor measurement indicative of an effect of the at least one drug on the patient; and
a processor configured, for each of a series of time steps, to determine a control signal and supply the control signal to the drug administration actuator to thereby cause the drug administration actuator to administer the at least one drug to the patient at a drug dosage rate which causes the monitor measurement to track a reference level;
wherein the processor is configured to implement a closed loop model-predictive control scheme which comprises, for each of the series of time steps, minimizing a cost function (performance index) subject to one or more constraints to thereby determine the control signal, the cost function based at least in part on the reference level and the monitor measurement;
wherein the processor is configured to use the control signal as an input to an auxiliary model and to use the auxiliary model and the control signal to estimate at least one concentration level of the at least one drug in the patient; and
wherein the drug dosage rate which the processor causes the drug administration actuator to administer is effected by varying a volume and/or concentration of the drug in a liquid or gas;
wherein the processor is configured to implement a robust model-predictive control scheme;
wherein the robust model-predictive control scheme causes the monitor measurement to track the reference level despite inter-patient variability within a population with respect to the effect of the at least one drug; and
wherein processor is configured to implement the robust model-predictive control scheme by using a nominal model that has been tuned with respect to quantified inter-patient uncertainty.

7. The control system of claim 6 wherein the nominal model is based on a combination of models from the population, with each model representing an effect of the drug on a corresponding member of the population.

8. The control system of claim 7 wherein the combination of models comprises an average of the models over the population.

9. The control system of claim 6 wherein the drug administration actuator comprises a controllable drug injection device.

10. The control system of claim 6 wherein the processor is configured, for each of the series of time steps, to determine the control signal and supply the control signal to the controllable injection device to thereby cause the controllable injection device to administer the at least one drug to the patient at a drug infusion rate which causes the monitor measurement to track the reference level.

Assignees

• Univ British Columbia

Inventors

• Dumont Guy
• Ansermino Mark
• Khosravi Sara
• West Nicholas

Classifications

• A61M2005/14296

  Pharmacokinetic models · CPC title

• A61B5/369

  Electroencephalography [EEG] · CPC title

• A61B5/4821 Primary

  Determining level or depth of anaesthesia (based on movements A61B5/1106) · CPC title

• A61M2202/048

  Anaesthetics · CPC title

• A61M2230/10

  Electroencephalographic signals · CPC title